SA-BRC announces the release of market assessment report on “Global Radiofrequency Ablation Devices for Dermatology & Cosmetology Market Assessment & Forecast 2017-2021“
The “Global Radiofrequency Ablation Devices for Dermatology & Cosmetology Market Assessment & Forecast 2017-2021”, estimates that the global radiofrequency ablation devices for dermatology & cosmetology market was valued at US$ 134.4 million in 2016 and expected to grow to US$ 221.0 million by 2021 at a CAGR of 7.8% from 2017 to 2021.
Skin tightening and rejuvenation is one of the most popular cosmetic procedures globally. With aging population and trend for ‘social media sharing’ large percentage of baby boomers are opting for skin rejuvenation procedures. Although injectables continue to be preferred alternative, patients are gradually shifting towards non-surgical treatments to avoid side effects. Global facial injectable procedures increased over 50% from 5,146,446 in 2010 to 7,730,464 in 2015, while non-surgical skin tightening procedures increased by 105% from 165,732 in 2010 to 340,609 in 2015 according to International Survey on Aesthetic/Cosmetic Procedures performed in 2015.
Radiofrequency skin rejuvenation market is competitive with over 15 players. Thermage by Solta (Valeant Pharmaceuticals) is a leading product in this segment. Large numbers of local players also exist in the market; however these players are more active in South East Asian countries where regulatory policies are less stringent. Microneedling has been used in cosmetic procedures for a long time, however the technology has gained increased adoption only recently. With growing number of players such as Ilooda, Lutronic, Lumenis, Jeisys, Inmode/Invasix and EndyMed the microneedling market is anticipated to grow significantly in the future driving the RF technology in aesthetics further. Medical tourism is the key factor driving RF ablation devices market in dermatology and cosmetology in the Asia Pacific region. Thailand, Singapore, South Korea, Malaysia and India are key destination in Asia Pacific region. North America and Europe account for a combined share of 63% in terms of value, although this share is expected to drop to 61% by 2021.
The report also segments the market by end-users that include hospitals and dermatology and cosmetology clinics. From the point-of-view of geography North America, Europe, Asia Pacific, Latin America and Middle East and Africa (MEA). The report also provides market share analysis of more than 10 players in the global market place, and mentions over 20 players marketing RF ablation devices for dermatology and cosmetology. Some of the key players in the market include Lumenis (Pollogen), Aesthetics Biomedical Inc., Alma Lasers, BTL Aesthetics, Almirall, F-Care Systems, Valeant Pharmaceuticals (Solta Medical) and various others.